Professional
Added to YB: 2026-06-19
Pitch date: 2026-03-31
AZN [bullish]
AstraZeneca PLC
-15.2%
current return
Author Info
No bio for this author
Company Info
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Market Cap
GBP 265.2B
Pitch Price
GBP 148.96
Price Target
N/A
Dividend
1.88%
EV/EBITDA
14.42
P/E
25.60
EV/Sales
4.77
Sector
Pharmaceuticals
Category
growth
Polen International Growth New Postion: AstraZeneca PLC
AZN (new position): UK biopharma transformed post-2010s patent cliffs into diversified portfolio across oncology, rare diseases, cardiovascular, renal/metabolic, respiratory/immunology. Strong oncology pipeline incl ADCs, plus obesity/hypertension drugs. Expect low double-digit shareholder returns through 2030.
Read full article (1 min)